1214 related articles for article (PubMed ID: 26671523)
21. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.
Lowres N; Krass I; Neubeck L; Redfern J; McLachlan AJ; Bennett AA; Freedman SB
Int J Clin Pharm; 2015 Dec; 37(6):1111-20. PubMed ID: 26202627
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing pharmacy services in opioid substitution treatment.
Chaar BB; Wang H; Day CA; Hanrahan JR; Winstock AR; Fois R
Drug Alcohol Rev; 2013 Jul; 32(4):426-34. PubMed ID: 23442133
[TBL] [Abstract][Full Text] [Related]
23. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
Alzubaidi H; Saidawi W; Mc Namara K
Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
[TBL] [Abstract][Full Text] [Related]
24. Community pharmacists' perceptions of services that benefit older people in New Zealand.
Tordoff J; Chang SY; Norris PT
Int J Clin Pharm; 2012 Apr; 34(2):342-50. PubMed ID: 22328011
[TBL] [Abstract][Full Text] [Related]
25. Establishment, Implementation, and Consolidation of Clinical Pharmacy Services in Community Pharmacies: Perceptions of a Group of Pharmacists.
Dosea AS; Brito GC; Santos LMC; Marques TC; Balisa-Rocha B; Pimentel D; Bueno D; Lyra DP
Qual Health Res; 2017 Feb; 27(3):363-373. PubMed ID: 26658232
[TBL] [Abstract][Full Text] [Related]
26. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan.
Hashmi FK; Hassali MA; Khalid A; Saleem F; Aljadhey H; Babar ZUD; Bashaar M
BMC Health Serv Res; 2017 Jul; 17(1):500. PubMed ID: 28724411
[TBL] [Abstract][Full Text] [Related]
27. Perceptions of a group of hospital pharmacists and other professionals of the implementation of clinical pharmacy at a high complexity public hospital in Brazil.
Alcântara TDS; Onozato T; Araújo Neto FC; Dosea AS; Cunha LC; de Araújo DCSA; Pimentel D; Lyra Junior DP
BMC Health Serv Res; 2018 Apr; 18(1):242. PubMed ID: 29618345
[TBL] [Abstract][Full Text] [Related]
28. Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists.
George J; Pfleger D; McCaig D; Bond C; Stewart D
Pharm World Sci; 2006 Apr; 28(2):45-53. PubMed ID: 16752193
[TBL] [Abstract][Full Text] [Related]
29. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
Gordon C; Unni E; Montuoro J; Ogborn DB
Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
[TBL] [Abstract][Full Text] [Related]
30. General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand.
Hatah E; Braund R; Duffull SB; Tordoff J
J Prim Health Care; 2013 Sep; 5(3):223-33. PubMed ID: 23998173
[TBL] [Abstract][Full Text] [Related]
31. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
Mandt I; Horn AM; Ekedahl A; Granas AG
Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
[TBL] [Abstract][Full Text] [Related]
32. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study.
Salgado TM; Moles R; Benrimoj SI; Fernandez-Llimos F
Int J Clin Pharm; 2012 Aug; 34(4):569-78. PubMed ID: 22538466
[TBL] [Abstract][Full Text] [Related]
33. A qualitative study of community pharmacists' opinions on the provision of osteoporosis disease state management services in Malaysia.
Nik J; Lai PS; Ng CJ; Emmerton L
BMC Health Serv Res; 2016 Aug; 16(1):448. PubMed ID: 27577560
[TBL] [Abstract][Full Text] [Related]
34. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
Puspitasari HP; Aslani P; Krass I
Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
[TBL] [Abstract][Full Text] [Related]
35. Supporting respiratory patients in primary care: a qualitative insight from independent community pharmacists in London.
Hesso I; Kayyali R; Nabhani-Gebara S
BMC Health Serv Res; 2019 Jan; 19(1):5. PubMed ID: 30611264
[TBL] [Abstract][Full Text] [Related]
36. Weight management in community pharmacy: what do the experts think?
Um IS; Armour C; Krass I; Gill T; Chaar BB
Int J Clin Pharm; 2013 Jun; 35(3):447-54. PubMed ID: 23456174
[TBL] [Abstract][Full Text] [Related]
37. Community pharmacists' educational needs for implementing clinical pharmacogenomic services.
Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE
J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787
[TBL] [Abstract][Full Text] [Related]
38. Pharmacists' views on and experiences with bowel cancer screening kits in Auckland, New Zealand.
Martini N; Basdew K; Kammona A; Shen A; Taylor C; McIntosh TR; Barnes J
Int J Pharm Pract; 2014 Aug; 22(4):257-64. PubMed ID: 24118479
[TBL] [Abstract][Full Text] [Related]
39. Cross-sectional survey of community pharmacists' views of the electronic Minor Ailment Service in Scotland.
Paudyal V; Hansford D; Scott Cunningham IT; Stewart D
Int J Pharm Pract; 2010 Aug; 18(4):194-201. PubMed ID: 20636670
[TBL] [Abstract][Full Text] [Related]
40. Community pharmacists' role in benzodiazepine supply in Ireland: a questionnaire of pharmacists' views and experiences.
Cadogan CA; Ryder SA
Int J Pharm Pract; 2015 Dec; 23(6):415-22. PubMed ID: 25756294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
